Market Outlook
The global Bioresorbable Vascular Scaffold market size was valued at USD 242.8 million in 2022 and is forecast to a readjusted size of USD 532.4 million by 2029 with a CAGR of 11.9% during review period.
Bioabsorbable scaffolds, or naturally dissolving stents, that have been investigated include base materials that are either metals or polymers. Those that have been approved in markets around the world and thus have gained the most traction are based on polymers that are similar to those used in dissolvable stitches. Bioresorbable Vascular Scaffold is the scaffold that used in vascular disease.
Global Bioresorbable Vascular Scaffold key players include Abbott, Kyoto Medical, Biotronik, Elixir Medical, etc. Global top four manufacturers hold a share about 99%. Europe is the largest market, with a share about 70%, followed by Asia Pacific, with a share about 20 percent. In terms of product, Polymer BVS is the largest segment, with a share about 90%. And in terms of application, the largest application is Hospital & Clinic, followed by Medical Center.
This report is a detailed and comprehensive analysis for global Bioresorbable Vascular Scaffold market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Bioresorbable Vascular Scaffold market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Bioresorbable Vascular Scaffold market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Bioresorbable Vascular Scaffold market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Bioresorbable Vascular Scaffold market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bioresorbable Vascular Scaffold
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bioresorbable Vascular Scaffold market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Abbott
Kyoto Medical
Biotronik
Elixir Medical
Segmentation By Type
Metal BVS
Polymer BVS
Segmentation By Application
Hospital & Clinic
Medical Center
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Bioresorbable Vascular Scaffold Market in 2025?
The market offers unique, patient-friendly alternatives to traditional metal stents, improving long-term outcomes by reducing the need for repeat procedures. Their biodegradability promotes natural vessel healing, which appeals to both healthcare providers and patients. Moreover, the rising demand for minimally invasive surgeries supports the growth of this market.
What weaknesses can be identified in the Bioresorbable Vascular Scaffold Market?
Bioresorbable vascular scaffolds face challenges in terms of long-term performance, as some products show limited mechanical strength during the critical healing phase. High manufacturing costs and complex regulatory approval processes may also slow market adoption. Furthermore, there is still a lack of widespread clinical data to guarantee their safety and efficacy in a variety of patient populations.
What opportunities exist for the Bioresorbable Vascular Scaffold Market in 2025?
The growing prevalence of cardiovascular diseases globally presents a significant opportunity. Advancements in material science could lead to more reliable and cost-effective scaffolds. Additionally, increased focus on personalized medicine and improved diagnostics could enhance the development and adoption of tailored solutions for patients.
What threats could affect the Bioresorbable Vascular Scaffold Market in 2025?
Competition from traditional metal stents and other innovative treatments, such as drug-eluting stents, poses a threat to market growth. Furthermore, regulatory hurdles and the uncertainty surrounding long-term efficacy could impede widespread adoption. There is also the challenge of convincing healthcare providers to switch from proven technologies to newer, untested options.
Market PESTEL Analysis
What are the political factors influencing the Bioresorbable Vascular Scaffold Market in 2025?
Government regulations and healthcare policies surrounding medical device approvals and reimbursement systems significantly impact the adoption of bioresorbable vascular scaffolds. Political stability and funding for healthcare research also play a role in the market’s growth, as support for cardiovascular treatments can drive innovations.
What economic factors are affecting the Bioresorbable Vascular Scaffold Market?
The high cost of manufacturing bioresorbable vascular scaffolds may limit their widespread adoption, especially in developing regions. However, economic growth in emerging markets and increasing healthcare expenditure can support the demand for advanced cardiovascular treatments, making these devices more accessible in the long run.
How do social factors influence the Bioresorbable Vascular Scaffold Market?
There is growing awareness and demand for minimally invasive procedures, as well as a rising emphasis on long-term health outcomes, especially among aging populations. Patients’ increasing preference for less invasive and more natural healing options boosts interest in bioresorbable scaffolds.
What technological factors are shaping the Bioresorbable Vascular Scaffold Market?
Advancements in materials science, such as the development of more durable and biocompatible materials, directly influence the performance of bioresorbable scaffolds. Additionally, innovations in medical imaging and surgical techniques help healthcare providers use these devices more effectively, contributing to market growth.
What environmental factors are relevant to the Bioresorbable Vascular Scaffold Market?
Environmental considerations, such as sustainability in the manufacturing process, may encourage companies to adopt eco-friendly practices. The biodegradability of the scaffolds aligns with growing environmental concerns, as it reduces the need for permanent implants and supports ecological safety in healthcare.
What legal factors impact the Bioresorbable Vascular Scaffold Market?
Compliance with strict regulatory standards for medical devices is crucial for market growth. Legal challenges related to product liability, intellectual property rights, and patent protections can influence the development and commercialization of bioresorbable vascular scaffolds.
Market SIPOC Analysis
What are the suppliers involved in the Bioresorbable Vascular Scaffold Market in 2025?
Suppliers include manufacturers of bioresorbable materials, advanced polymers, and specialized coatings used in scaffold production. Additionally, companies providing cutting-edge technology for scaffold design, as well as regulatory bodies ensuring compliance, play an important role in the supply chain.
What inputs are required for the Bioresorbable Vascular Scaffold Market?
Key inputs include research and development resources, advanced materials like biodegradable polymers, and machinery for precision manufacturing. Furthermore, clinical trial data, regulatory approval processes, and the availability of skilled medical professionals for product implantation are vital inputs for market success.
What process steps are involved in the Bioresorbable Vascular Scaffold Market?
The process involves extensive R&D for material innovation, followed by design and prototype testing. Once approved, manufacturing, packaging, and distribution occur. Clinical trials and post-market surveillance are ongoing to ensure safety and effectiveness, with final implantation by skilled surgeons in a hospital setting.
What are the outputs of the Bioresorbable Vascular Scaffold Market?
The output is the bioresorbable vascular scaffold itself, which is used for minimally invasive coronary procedures. Other outputs include the associated medical data, research findings, and clinical reports that contribute to the continued development and refinement of the product.
Who are the customers in the Bioresorbable Vascular Scaffold Market?
Customers include hospitals, cardiology clinics, and healthcare providers, along with patients requiring coronary interventions. Additionally, the market extends to insurance companies who cover the costs of the procedure and regulatory bodies that monitor product safety.
Market Porter's Five Forces
How strong is the threat of new entrants in the Bioresorbable Vascular Scaffold Market?
The threat of new entrants is moderate. While the potential for growth in the market is attractive, the high costs of research, development, and regulatory approval present significant barriers to entry. Additionally, existing players already have strong brand recognition and technological expertise, making it difficult for new companies to compete at scale.
How intense is the bargaining power of suppliers in the Bioresorbable Vascular Scaffold Market?
The bargaining power of suppliers is moderate to high. The market relies on specialized materials like biodegradable polymers and coatings, and there are limited suppliers for these advanced materials. However, with increasing demand for bioresorbable scaffolds, suppliers may have more opportunities to increase their influence on pricing and terms.
What is the bargaining power of buyers in the Bioresorbable Vascular Scaffold Market?
The bargaining power of buyers is moderate. Hospitals and healthcare providers can negotiate pricing, especially as more competitors enter the market. However, since bioresorbable vascular scaffolds are a niche, high-tech product with specialized applications, buyers have limited options, which reduces their bargaining power to some extent.
How strong is the threat of substitute products in the Bioresorbable Vascular Scaffold Market?
The threat of substitutes is moderate. Traditional metal stents and drug-eluting stents are established alternatives, offering lower costs and well-documented performance. However, the unique benefits of bioresorbable scaffolds, such as natural vessel healing and minimal long-term intervention, provide them with a distinct advantage, making substitution less likely for certain patient groups.
How intense is the rivalry among existing competitors in the Bioresorbable Vascular Scaffold Market?
Rivalry among existing competitors is moderate to high. While there are only a few major players currently dominating the market, the competition is expected to intensify as the market grows. Companies are racing to innovate and secure market share by improving product performance, reducing costs, and expanding their clinical data.
Market Upstream Analysis
What are the key upstream factors influencing the Bioresorbable Vascular Scaffold Market?
The key upstream factors include the availability and cost of raw materials like biodegradable polymers and advanced biomaterials. Research and development efforts in material science play a critical role in shaping the production of bioresorbable scaffolds. Additionally, the regulatory environment and approval processes impact the speed at which innovations move to the market.
How do suppliers and manufacturers impact the Bioresorbable Vascular Scaffold Market?
Suppliers of specialized materials and advanced technologies are crucial for the production of bioresorbable scaffolds. Manufacturers rely heavily on these upstream partners for high-quality, biocompatible materials. Any disruption in the supply chain or increase in raw material costs can affect the production timeline and cost-efficiency of scaffolds.
What role does technology development play in the upstream analysis of the Bioresorbable Vascular Scaffold Market?
Technological advancements in materials science, manufacturing techniques, and product design are essential to improving the performance and durability of bioresorbable scaffolds. Breakthroughs in biodegradable polymers and 3D printing technologies are particularly important for improving the functionality and cost-effectiveness of these devices.
How do regulatory requirements affect the upstream market for Bioresorbable Vascular Scaffolds?
Regulatory requirements significantly impact the upstream activities of the market, as manufacturers must meet stringent quality and safety standards. The lengthy and complex approval process from regulatory bodies such as the FDA can delay the introduction of new products, requiring manufacturers to invest considerable resources in clinical trials and compliance efforts.
How does the competitive landscape upstream affect the Bioresorbable Vascular Scaffold Market?
Upstream competition, particularly among suppliers of raw materials and technology developers, drives innovation and affects pricing structures. Companies that invest in improving material properties or developing new manufacturing methods can give themselves a competitive edge, influencing the overall supply chain efficiency and cost-effectiveness of the market.
Market Midstream Analysis
What are the key midstream factors affecting the Bioresorbable Vascular Scaffold Market?
Key midstream factors include the manufacturing processes, quality control standards, and distribution channels. The ability to scale production efficiently and ensure consistent product quality is crucial. Additionally, the management of supply chains for distributing these specialized devices to hospitals and clinics impacts overall market performance.
How do manufacturing and production processes influence the Bioresorbable Vascular Scaffold Market?
The production of bioresorbable vascular scaffolds requires highly specialized manufacturing processes, including precise molding and coating techniques to ensure optimal performance and safety. Advances in automation and precision manufacturing can reduce costs and improve production efficiency, directly affecting the market's competitiveness.
What role does quality control play in the midstream analysis of the Bioresorbable Vascular Scaffold Market?
Quality control is vital for ensuring that each bioresorbable vascular scaffold meets stringent safety and performance standards. Rigorous testing during production, such as mechanical strength and biocompatibility assessments, ensures that the devices are reliable and effective in clinical settings, which is essential for patient safety and regulatory approval.
How do logistics and distribution impact the Bioresorbable Vascular Scaffold Market?
Efficient logistics and distribution systems are crucial to ensure that bioresorbable vascular scaffolds reach healthcare facilities on time. Any delays or disruptions in the supply chain can lead to shortages, affecting patient access to treatment and potentially increasing costs for healthcare providers.
How does the competitive environment in the midstream affect the Bioresorbable Vascular Scaffold Market?
The competitive environment in the midstream affect's product pricing, manufacturing efficiency, and technological innovation. Companies competing in the midstream must continuously improve their manufacturing processes and supply chain management to reduce costs and maintain high-quality standards, which in turn influences their market share and profitability.
Market Downstream Analysis
What are the key downstream factors influencing the Bioresorbable Vascular Scaffold Market?
Key downstream factors include the adoption of bioresorbable vascular scaffolds by healthcare providers, such as hospitals and cardiology clinics. Physician awareness, training, and comfort with these new devices are critical for market penetration. Additionally, patient demand for innovative and less invasive treatment options plays a significant role in driving downstream success.
How does physician adoption impact the Bioresorbable Vascular Scaffold Market?
Physician adoption is vital for the downstream success of bioresorbable scaffolds. Doctors need to be convinced of the long-term benefits and reliability of these devices compared to traditional stents. Continuous education and clinical evidence supporting the safety and efficacy of these scaffolds will drive wider usage among healthcare professionals.
How does patient demand influence the Bioresorbable Vascular Scaffold Market?
Patient demand for less invasive, more natural treatments is increasing, especially among those seeking alternatives to permanent implants. The growing awareness of bioresorbable scaffolds as a solution for cardiovascular disease helps to increase their demand, pushing healthcare providers to offer them as treatment options.
What role do reimbursement policies play in the Bioresorbable Vascular Scaffold Market?
Reimbursement policies significantly affect the accessibility and affordability of bioresorbable scaffolds. If insurance companies offer favorable reimbursement terms for these devices, adoption rates will increase. However, limited reimbursement or high out-of-pocket costs can hinder patient access and slow market growth.
How do regulatory approvals and clinical data impact the downstream success of the Bioresorbable Vascular Scaffold Market?
Regulatory approvals and robust clinical data are essential for downstream success. Positive outcomes from clinical trials and regulatory certifications (e.g., FDA approval) help build trust among healthcare providers and patients. Without solid clinical evidence and proper certifications, the adoption of these scaffolds may be limited despite their potential benefits.
Chapter 1, to describe Bioresorbable Vascular Scaffold product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bioresorbable Vascular Scaffold, with price, sales, revenue and global market share of Bioresorbable Vascular Scaffold from 2018 to 2023.
Chapter 3, the Bioresorbable Vascular Scaffold competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bioresorbable Vascular Scaffold breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Bioresorbable Vascular Scaffold market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bioresorbable Vascular Scaffold.
Chapter 14 and 15, to describe Bioresorbable Vascular Scaffold sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Bioresorbable Vascular Scaffold
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Bioresorbable Vascular Scaffold Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Metal BVS
1.3.3 Polymer BVS
1.4 Market Analysis by Application
1.4.1 Overview: Global Bioresorbable Vascular Scaffold Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital & Clinic
1.4.3 Medical Center
1.5 Global Bioresorbable Vascular Scaffold Market Size & Forecast
1.5.1 Global Bioresorbable Vascular Scaffold Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Bioresorbable Vascular Scaffold Sales Quantity (2018-2029)
1.5.3 Global Bioresorbable Vascular Scaffold Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Bioresorbable Vascular Scaffold Product and Services
2.1.4 Abbott Bioresorbable Vascular Scaffold Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Recent Developments/Updates
2.2 Kyoto Medical
2.2.1 Kyoto Medical Details
2.2.2 Kyoto Medical Major Business
2.2.3 Kyoto Medical Bioresorbable Vascular Scaffold Product and Services
2.2.4 Kyoto Medical Bioresorbable Vascular Scaffold Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Kyoto Medical Recent Developments/Updates
2.3 Biotronik
2.3.1 Biotronik Details
2.3.2 Biotronik Major Business
2.3.3 Biotronik Bioresorbable Vascular Scaffold Product and Services
2.3.4 Biotronik Bioresorbable Vascular Scaffold Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Biotronik Recent Developments/Updates
2.4 Elixir Medical
2.4.1 Elixir Medical Details
2.4.2 Elixir Medical Major Business
2.4.3 Elixir Medical Bioresorbable Vascular Scaffold Product and Services
2.4.4 Elixir Medical Bioresorbable Vascular Scaffold Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Elixir Medical Recent Developments/Updates
3 Competitive Environment: Bioresorbable Vascular Scaffold by Manufacturer
3.1 Global Bioresorbable Vascular Scaffold Sales Quantity by Manufacturer (2018-2023)
3.2 Global Bioresorbable Vascular Scaffold Revenue by Manufacturer (2018-2023)
3.3 Global Bioresorbable Vascular Scaffold Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Bioresorbable Vascular Scaffold by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Bioresorbable Vascular Scaffold Manufacturer Market Share in 2022
3.4.2 Top 6 Bioresorbable Vascular Scaffold Manufacturer Market Share in 2022
3.5 Bioresorbable Vascular Scaffold Market: Overall Company Footprint Analysis
3.5.1 Bioresorbable Vascular Scaffold Market: Region Footprint
3.5.2 Bioresorbable Vascular Scaffold Market: Company Product Type Footprint
3.5.3 Bioresorbable Vascular Scaffold Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Bioresorbable Vascular Scaffold Market Size by Region
4.1.1 Global Bioresorbable Vascular Scaffold Sales Quantity by Region (2018-2029)
4.1.2 Global Bioresorbable Vascular Scaffold Consumption Value by Region (2018-2029)
4.1.3 Global Bioresorbable Vascular Scaffold Average Price by Region (2018-2029)
4.2 North America Bioresorbable Vascular Scaffold Consumption Value (2018-2029)
4.3 Europe Bioresorbable Vascular Scaffold Consumption Value (2018-2029)
4.4 Asia-Pacific Bioresorbable Vascular Scaffold Consumption Value (2018-2029)
4.5 South America Bioresorbable Vascular Scaffold Consumption Value (2018-2029)
4.6 Middle East and Africa Bioresorbable Vascular Scaffold Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2029)
5.2 Global Bioresorbable Vascular Scaffold Consumption Value by Type (2018-2029)
5.3 Global Bioresorbable Vascular Scaffold Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2029)
6.2 Global Bioresorbable Vascular Scaffold Consumption Value by Application (2018-2029)
6.3 Global Bioresorbable Vascular Scaffold Average Price by Application (2018-2029)
7 North America
7.1 North America Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2029)
7.2 North America Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2029)
7.3 North America Bioresorbable Vascular Scaffold Market Size by Country
7.3.1 North America Bioresorbable Vascular Scaffold Sales Quantity by Country (2018-2029)
7.3.2 North America Bioresorbable Vascular Scaffold Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2029)
8.2 Europe Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2029)
8.3 Europe Bioresorbable Vascular Scaffold Market Size by Country
8.3.1 Europe Bioresorbable Vascular Scaffold Sales Quantity by Country (2018-2029)
8.3.2 Europe Bioresorbable Vascular Scaffold Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Bioresorbable Vascular Scaffold Market Size by Region
9.3.1 Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Bioresorbable Vascular Scaffold Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2029)
10.2 South America Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2029)
10.3 South America Bioresorbable Vascular Scaffold Market Size by Country
10.3.1 South America Bioresorbable Vascular Scaffold Sales Quantity by Country (2018-2029)
10.3.2 South America Bioresorbable Vascular Scaffold Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Bioresorbable Vascular Scaffold Market Size by Country
11.3.1 Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Bioresorbable Vascular Scaffold Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Bioresorbable Vascular Scaffold Market Drivers
12.2 Bioresorbable Vascular Scaffold Market Restraints
12.3 Bioresorbable Vascular Scaffold Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Bioresorbable Vascular Scaffold and Key Manufacturers
13.2 Manufacturing Costs Percentage of Bioresorbable Vascular Scaffold
13.3 Bioresorbable Vascular Scaffold Production Process
13.4 Bioresorbable Vascular Scaffold Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Bioresorbable Vascular Scaffold Typical Distributors
14.3 Bioresorbable Vascular Scaffold Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Bioresorbable Vascular Scaffold Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Bioresorbable Vascular Scaffold Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Bioresorbable Vascular Scaffold Product and Services
Table 6. Abbott Bioresorbable Vascular Scaffold Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Recent Developments/Updates
Table 8. Kyoto Medical Basic Information, Manufacturing Base and Competitors
Table 9. Kyoto Medical Major Business
Table 10. Kyoto Medical Bioresorbable Vascular Scaffold Product and Services
Table 11. Kyoto Medical Bioresorbable Vascular Scaffold Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Kyoto Medical Recent Developments/Updates
Table 13. Biotronik Basic Information, Manufacturing Base and Competitors
Table 14. Biotronik Major Business
Table 15. Biotronik Bioresorbable Vascular Scaffold Product and Services
Table 16. Biotronik Bioresorbable Vascular Scaffold Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Biotronik Recent Developments/Updates
Table 18. Elixir Medical Basic Information, Manufacturing Base and Competitors
Table 19. Elixir Medical Major Business
Table 20. Elixir Medical Bioresorbable Vascular Scaffold Product and Services
Table 21. Elixir Medical Bioresorbable Vascular Scaffold Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Elixir Medical Recent Developments/Updates
Table 23. Global Bioresorbable Vascular Scaffold Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 24. Global Bioresorbable Vascular Scaffold Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Bioresorbable Vascular Scaffold Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 26. Market Position of Manufacturers in Bioresorbable Vascular Scaffold, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Bioresorbable Vascular Scaffold Production Site of Key Manufacturer
Table 28. Bioresorbable Vascular Scaffold Market: Company Product Type Footprint
Table 29. Bioresorbable Vascular Scaffold Market: Company Product Application Footprint
Table 30. Bioresorbable Vascular Scaffold New Market Entrants and Barriers to Market Entry
Table 31. Bioresorbable Vascular Scaffold Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Bioresorbable Vascular Scaffold Sales Quantity by Region (2018-2023) & (K Units)
Table 33. Global Bioresorbable Vascular Scaffold Sales Quantity by Region (2024-2029) & (K Units)
Table 34. Global Bioresorbable Vascular Scaffold Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Bioresorbable Vascular Scaffold Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Bioresorbable Vascular Scaffold Average Price by Region (2018-2023) & (USD/Unit)
Table 37. Global Bioresorbable Vascular Scaffold Average Price by Region (2024-2029) & (USD/Unit)
Table 38. Global Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2023) & (K Units)
Table 39. Global Bioresorbable Vascular Scaffold Sales Quantity by Type (2024-2029) & (K Units)
Table 40. Global Bioresorbable Vascular Scaffold Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Bioresorbable Vascular Scaffold Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Bioresorbable Vascular Scaffold Average Price by Type (2018-2023) & (USD/Unit)
Table 43. Global Bioresorbable Vascular Scaffold Average Price by Type (2024-2029) & (USD/Unit)
Table 44. Global Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2023) & (K Units)
Table 45. Global Bioresorbable Vascular Scaffold Sales Quantity by Application (2024-2029) & (K Units)
Table 46. Global Bioresorbable Vascular Scaffold Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Bioresorbable Vascular Scaffold Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Bioresorbable Vascular Scaffold Average Price by Application (2018-2023) & (USD/Unit)
Table 49. Global Bioresorbable Vascular Scaffold Average Price by Application (2024-2029) & (USD/Unit)
Table 50. North America Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Bioresorbable Vascular Scaffold Sales Quantity by Type (2024-2029) & (K Units)
Table 52. North America Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2023) & (K Units)
Table 53. North America Bioresorbable Vascular Scaffold Sales Quantity by Application (2024-2029) & (K Units)
Table 54. North America Bioresorbable Vascular Scaffold Sales Quantity by Country (2018-2023) & (K Units)
Table 55. North America Bioresorbable Vascular Scaffold Sales Quantity by Country (2024-2029) & (K Units)
Table 56. North America Bioresorbable Vascular Scaffold Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Bioresorbable Vascular Scaffold Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Europe Bioresorbable Vascular Scaffold Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Europe Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2023) & (K Units)
Table 61. Europe Bioresorbable Vascular Scaffold Sales Quantity by Application (2024-2029) & (K Units)
Table 62. Europe Bioresorbable Vascular Scaffold Sales Quantity by Country (2018-2023) & (K Units)
Table 63. Europe Bioresorbable Vascular Scaffold Sales Quantity by Country (2024-2029) & (K Units)
Table 64. Europe Bioresorbable Vascular Scaffold Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Bioresorbable Vascular Scaffold Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity by Type (2024-2029) & (K Units)
Table 68. Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity by Application (2024-2029) & (K Units)
Table 70. Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity by Region (2018-2023) & (K Units)
Table 71. Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity by Region (2024-2029) & (K Units)
Table 72. Asia-Pacific Bioresorbable Vascular Scaffold Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Bioresorbable Vascular Scaffold Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2023) & (K Units)
Table 75. South America Bioresorbable Vascular Scaffold Sales Quantity by Type (2024-2029) & (K Units)
Table 76. South America Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2023) & (K Units)
Table 77. South America Bioresorbable Vascular Scaffold Sales Quantity by Application (2024-2029) & (K Units)
Table 78. South America Bioresorbable Vascular Scaffold Sales Quantity by Country (2018-2023) & (K Units)
Table 79. South America Bioresorbable Vascular Scaffold Sales Quantity by Country (2024-2029) & (K Units)
Table 80. South America Bioresorbable Vascular Scaffold Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Bioresorbable Vascular Scaffold Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity by Type (2018-2023) & (K Units)
Table 83. Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity by Type (2024-2029) & (K Units)
Table 84. Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity by Region (2018-2023) & (K Units)
Table 87. Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity by Region (2024-2029) & (K Units)
Table 88. Middle East & Africa Bioresorbable Vascular Scaffold Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Bioresorbable Vascular Scaffold Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Bioresorbable Vascular Scaffold Raw Material
Table 91. Key Manufacturers of Bioresorbable Vascular Scaffold Raw Materials
Table 92. Bioresorbable Vascular Scaffold Typical Distributors
Table 93. Bioresorbable Vascular Scaffold Typical Customers
List of Figures
Figure 1. Bioresorbable Vascular Scaffold Picture
Figure 2. Global Bioresorbable Vascular Scaffold Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Bioresorbable Vascular Scaffold Consumption Value Market Share by Type in 2022
Figure 4. Metal BVS Examples
Figure 5. Polymer BVS Examples
Figure 6. Global Bioresorbable Vascular Scaffold Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Bioresorbable Vascular Scaffold Consumption Value Market Share by Application in 2022
Figure 8. Hospital & Clinic Examples
Figure 9. Medical Center Examples
Figure 10. Global Bioresorbable Vascular Scaffold Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Bioresorbable Vascular Scaffold Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Bioresorbable Vascular Scaffold Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Bioresorbable Vascular Scaffold Average Price (2018-2029) & (USD/Unit)
Figure 14. Global Bioresorbable Vascular Scaffold Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Bioresorbable Vascular Scaffold Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Bioresorbable Vascular Scaffold by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Bioresorbable Vascular Scaffold Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Bioresorbable Vascular Scaffold Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Bioresorbable Vascular Scaffold Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Bioresorbable Vascular Scaffold Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Bioresorbable Vascular Scaffold Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Bioresorbable Vascular Scaffold Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Bioresorbable Vascular Scaffold Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Bioresorbable Vascular Scaffold Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Bioresorbable Vascular Scaffold Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Bioresorbable Vascular Scaffold Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Bioresorbable Vascular Scaffold Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Bioresorbable Vascular Scaffold Average Price by Type (2018-2029) & (USD/Unit)
Figure 29. Global Bioresorbable Vascular Scaffold Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Bioresorbable Vascular Scaffold Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Bioresorbable Vascular Scaffold Average Price by Application (2018-2029) & (USD/Unit)
Figure 32. North America Bioresorbable Vascular Scaffold Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Bioresorbable Vascular Scaffold Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Bioresorbable Vascular Scaffold Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Bioresorbable Vascular Scaffold Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Bioresorbable Vascular Scaffold Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Bioresorbable Vascular Scaffold Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Bioresorbable Vascular Scaffold Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Bioresorbable Vascular Scaffold Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Bioresorbable Vascular Scaffold Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Bioresorbable Vascular Scaffold Consumption Value Market Share by Region (2018-2029)
Figure 52. China Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Bioresorbable Vascular Scaffold Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Bioresorbable Vascular Scaffold Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Bioresorbable Vascular Scaffold Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Bioresorbable Vascular Scaffold Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Bioresorbable Vascular Scaffold Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Bioresorbable Vascular Scaffold Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Bioresorbable Vascular Scaffold Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Bioresorbable Vascular Scaffold Market Drivers
Figure 73. Bioresorbable Vascular Scaffold Market Restraints
Figure 74. Bioresorbable Vascular Scaffold Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Bioresorbable Vascular Scaffold in 2022
Figure 77. Manufacturing Process Analysis of Bioresorbable Vascular Scaffold
Figure 78. Bioresorbable Vascular Scaffold Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
